Login

Financial Snapshot

Revenue
TTM
$1.454B
Gross Margin
TTM
67.35%
Net Income
TTM
$171.0M
Current Assets
2026 Q1
Current Liabilities
2026 Q1
Current Ratio
2026 Q1
602.37%
Total Assets
2026 Q1
Total Liabilities
2026 Q1
Book Value
2026 Q1
$1.474B
Cash
2026 Q1
P/E
TTM
73.44
Free Cash Flow
TTM
$212.7M

Stock Price

Loading...
Market Cap: $12.561 Billion

About Penumbra Inc

Penumbra Inc (NYSE: PEN) is a medical device company that develops and sells products for the treatment of vascular and neuro conditions. The filing excerpts provided do not contain sufficient detail to describe Penumbra's revenue model, segment breakdown, product portfolio, geographic footprint, competitive position, or financial metrics with the specificity required. Based solely on the excerpts supplied from the 10-K filed 2026-02-25 (accession 000132173226000007), no further supported statements can be made about the company's business model, customers, or market position.

Source: SEC 10-K, filed 2026-02-25

Industry: Surgical & Medical Instruments & Apparatus Peers: Abbott Laboratories ABIOMED INC QuidelOrtho Corp Envista Holdings Corp Globus Medical Inc Inspire Medical Systems Inc Masimo Corp Shockwave Medical, Inc. Teleflex Inc

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support